Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Significant boost for infrastructure development
2012-12-28

The University of the Free State (UFS) recently received a significant boost for its infrastructure development with the approval of infrastructure projects totalling
R333,600 million by the Department of Higher Education and Training for the next three years.

The funding includes cost sharing, with the department contributing R208,394 million and the UFS contributing an amount of R125,206 million.

The UFS Council approved the projects and the cost sharing during the last meeting for the year on 16 November 2012.

“We are elated by the generous funding received from the department as it will assist us in fast-tracking our infrastructure development, providing in the increasing need for new and upgraded facilities at all three campuses,” said Prof. Nicky Morgan, Vice-Rector: Operations.

The projects include:

  • Upgrading and new disability access to various buildings on the Bloemfontein, South and Qwaqwa Campuses;
  • A building in Kimberley, which will be shared by the School for Allied Health Professionals and Nursing;
  • Upgrading and extension of the biotechnology and nutrition facilities, additional infrastructure for the Department of Physics and the upgrading of an extension to the genetic sciences facilities on the Bloemfontein Campus;
  • A new 250-bed student residence on the Bloemfontein and Qwaqwa Campusus, respectively;
  • Facilities for the Faculty of Education;
  • Six lecture rooms on the South Campus;
  • Upgrading of the interpreting laboratory and the development of an audio-visual production facility for recording of lectures on the Bloemfontein Campus;
  • Provision of office space for the Centre for Teaching and Learning on the Bloemfontein Campus;
  • Lecture halls and a laboratory for the Department of Geography and Tourism on the Qwaqwa Campus; and
  • Funding of additional infrastructure for the Department of Physics on the Qwaqwa Campus.

 “The department made special mention of the way the UFS manages its infrastructure and efficiency funding when the announcement about the allocation of funds was made. This is a feather in our cap as the department has been referring other higher education institutions to the UFS for advice on infrastructure development,” he said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept